SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005; 55: 74108.
  • 2
    El-Serag HB, Mason AC. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med. 1999; 340: 745750.
  • 3
    Howe HL, Wu X, Ries LA, et al. Annual report to the nation on the status of cancer, 1975–2003, featuring cancer among U.S. Hispanic/Latino populations. Cancer. 2006; 107: 17111742.
  • 4
    McGlynn KA, Tarone RE, El-Serag HB. A comparison of trends in the incidence of hepatocellular carcinoma and intrahepatic cholangiocarcinoma in the United States. Cancer Epidemiol Biomarkers Prev. 2006; 15: 11981203.
  • 5
    Chen MSJr. Cancer health disparities among Asian Americans: what we do and what we need to do. Cancer. 2005; 104( 12 suppl): 28952902.
  • 6
    United States Census Bureau. Hispanic and Asian Americans increasing faster than overall population. Available at URL: http://www.census.gov/Press-Release/www/releases/archives/race/001839.html Accessed February 18, 2006.
  • 7
    United States Census Bureau. 2005 American Community Survey. Washington, DC: U.S. Department of Commerce, Economics and Statistics Administration; 2006.
  • 8
    PercyC, Van HoltenB, MuirC, eds. International Classification of Diseases for Oncology, 2nd ed. Geneva: World Health Organization; 1990.
  • 9
    FritzA, PercyC, JackASS, SobinL, ParkinDM, WhelanS, eds. International Classification of Diseases for Oncology, 3rd edition. Geneva: World Health Organization; 2000: 240.
  • 10
    Gomez SL, Le GM, West DW, Satariano WA, O'Connor L. Hospital policy and practice regarding the collection of data on race, ethnicity, and birthplace. Am J Public Health. 2003; 93: 16851688.
  • 11
    United States Census Bureau. Census 2000 Summary File 2. Washington, DC: U.S. Department of Commerce, Economics and Statistics Administration; 2001.
  • 12
    State of California Department of Finance. Suggested Allocations of the Multirace Category for Use with Population Projections by Race/Ethnicity for California and its Counties, 2000–2050. Sacramento, Calif: State of California Department of Finance; 2004.
  • 13
    Gomez SL, Le GM, Miller T, et al., Cancer Incidence Among Asians in the Greater Bay Area, 1990–2002. Northern California Cancer Center, 2005. Available at URL:http://www.nccc.org/pdf/Registries/annual_reports/Special_Report_Cancer_Asians_1990-2002.pdf [Accessed February 1, 2007].
  • 14
    Shryock HS, Siegel JS. The Methods and Materials of Demography. Washington, DC: United States Bureau of the Census; 1973.
  • 15
    Surveillance Research Program, National Cancer Institute. SEER*Stat software, version 6.1.4, 2005. Available at URL: http://www.seer.cancer.gov/seerstat [Accessed February 1, 2007].
  • 16
    Surveillance Research Program, National Cancer Institute. Joinpoint Regression Program software, version 3.0, 2005. Available at URL: http://www.srab.cancer.gov/joinpoint [Accessed February 1, 2007].
  • 17
    Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med. 2000; 19: 335351.
  • 18
    American Cancer Society. Cancer Facts and Figures, 2007. Atlanta: American Cancer Society; 2007.
  • 19
    Harper S, Lynch J. Methods for Measuring Cancer Disparities: Using Data Relevant to Healthy People 2010 Cancer-related Objectives. NCI Cancer Surveillance Monograph Series, no. 6. NIH publication no. 05–5777. Bethesda, MD: National Cancer Institute; 2005.
  • 20
    Parkin DM, Whelan SL, Ferlay J, Storm H. Cancer Incidence in Five Continents, vol I-VIII [updated and original databases available at URL: http://www.dep.iarc.fr/] Cancer Base no.7. Lyon, France: IARC; 2005.
  • 21
    Armstrong GL, Alter MJ, McQuillan GM, Margolis HS. The past incidence of hepatitis C virus infection: implications for the future burden of chronic liver disease in the United States. Hepatology. 2000; 31: 777782.
  • 22
    Parkin DM. The global health burden of infection-associated cancers in the year 2002. Int J Cancer. 2006; 118: 30303044.
  • 23
    Hwang SJ, Tong MJ, Lai PP, et al. Evaluation of hepatitis B and C viral markers: clinical significance in Asian and Caucasian patients with hepatocellular carcinoma in the United States of America. J Gastroenterol Hepatol. 1996; 11: 949954.
  • 24
    Custer B, Sullivan SD, Hazlet TK, Iloeje U, Veenstra DL, Kowdley KV. Global epidemiology of hepatitis B virus. J Clin Gastroenterol. 2004; 38( 10 suppl): S158S168.
  • 25
    Daniels R. Asian America: Chinese and Japanese in the United States Since 1850. Seattle: University of Washington Press; 1988.
  • 26
    El-Serag HB, Mason AC. Risk factors for the rising rates of primary liver cancer in the United States. Arch Intern Med. 2000; 160: 32273230.
  • 27
    Hassan MM, Frome A, Patt YZ, El-Serag HB. Rising prevalence of hepatitis C virus infection among patients recently diagnosed with hepatocellular carcinoma in the United States. J Clin Gastroenterol. 2002; 35: 266269.
  • 28
    Centers for Disease Control and Prevention (CDC). Hepatitis B virus: a comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination. Recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR Recomm Rep. 1991; 40(RR-13): 125.
  • 29
    Chen DS, Hsu NH, Sung JL, et al. A mass vaccination program in Taiwan against hepatitis B virus infection in infants of hepatitis B surface antigen-carrier mothers. JAMA. 1987; 257: 25972603.
  • 30
    Chen HL, Chang MH, Ni YH, et al. Seroepidemiology of hepatitis B virus infection in children: ten years of mass vaccination in Taiwan. JAMA. 1996; 276: 906908.
  • 31
    Ng KP, Saw TL, Baki A, Rozainah K, Pang KW, Ramanathan M. Impact of the Expanded Program of Immunization against hepatitis B infection in school children in Malaysia. Med Microbiol Immunol (Berlin). 2005; 194: 163168.
  • 32
    United States Census Bureau. We the People: Asians in the United States. Census 2000 Special Reports. Washington, DC: U.S. Department of Commerce, Economics and Statistics Administration; 2004.
  • 33
    Dienstag JL, Schiff ER, Wright TL, et al. Lamivudine as initial treatment for chronic hepatitis B in the United States. N Engl J Med. 1999; 341: 12561263.
  • 34
    Nguyen MH, Keeffe EB. Screening for hepatocellular carcinoma. J Clin Gastroenterol. 2002; 35(5 suppl 2): S86S91.
  • 35
    Centers for Disease Control and Prevention (CDC). Immunization of adolescents. Recommendations of the Advisory Committee on Immunization Practices, the American Academy of Pediatrics, the American Academy of Family Physicians, and the American Medical Association. MMWR Recomm Rep. 1996; 45(RR-13): 116.
  • 36
    Centers for Disease Control and Prevention (CDC). Update: recommendations to prevent hepatitis B virus transmission—United States. MMWR Morb Mortal Wkly Rep. 1999; 48: 3334.
  • 37
    Coleman PJ, McQuillan GM, Moyer LA, Lambert SB, Margolis HS. Incidence of hepatitis B virus infection in the United States, 1976–1994: estimates from the National Health and Nutrition Examination Surveys. J Infect Dis. 1998; 178: 954959.
  • 38
    Hoofnagle JH. Hepatitis B—preventable and now treatable. N Engl J Med. 2006; 354: 10741076.
  • 39
    Swallen KC, Glaser SL, Stewart SL, West DW, Jenkins CN, McPhee SJ. Accuracy of racial classification of Vietnamese patients in a population-based cancer registry. Ethn Dis. 1998; 8: 218227.
  • 40
    Gomez SL, Glaser SL, Kelsey JL, Lee MM, Sidney S. Inconsistencies between self-reported ethnicity and ethnicity recorded in a health maintenance organization. Ann Epidemiol. 2005; 15: 7179.
  • 41
    Gomez SL, Glaser SL. Misclassification of race/ethnicity in a population-based cancer registry (United States). Cancer Causes Control. 2006; 17: 771681.